Back to Business

FDA grants priority review for Enspryng in rare disease MOGAD

Business September 10, 2026 at 5:20 AM

FDA grants priority review for Enspryng in rare disease MOGAD

Investing.com

Read at Investing.com

More Stories

Asia stocks fall with oil surge, yields in focus; U.S. inflation on tap

Asia stocks fall with oil surge, yields in focus; U.S. inflation on tap

🇺🇸 Investing.com 17m ago

UK’s smallest investment funds show weak cybersecurity defenses

UK’s smallest investment funds show weak cybersecurity defenses

🇺🇸 Investing.com 20m ago

China AI chipmakers hike prices as HBM shortage hits domestic push - Reuters

China AI chipmakers hike prices as HBM shortage hits domestic push - Reuters

🇺🇸 Investing.com 22m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play